Clinical Trial Update: Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of insulin-like growth factor I in adults on hemodialysis has completed (NCT01209403).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Insulin-like Growth Factor I (insulin-like growth factor I)

Snippet

Sponsor: University of Aarhus | Conditions: Kidney Failure, Chronic | Phase 4 | Status: COMPLETED